Published in Ann Am Thorac Soc on January 01, 2014
Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med (2006) 24.38
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med (2013) 8.21
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax (2004) 8.09
Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis (2011) 7.41
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis (2009) 6.17
Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest (2005) 4.41
Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One (2008) 3.85
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology (2008) 3.00
HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med (2010) 3.00
Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One (2010) 2.60
Primary pulmonary hypertension in HIV infection. Chest (1991) 2.40
Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.29
Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest (1995) 2.22
Pulmonary hypertension in COPD. Eur Respir J (2008) 2.03
Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS (2013) 1.92
Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med (1997) 1.91
Serum (1-->3) beta-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin Infect Dis (2009) 1.91
Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med (2007) 1.90
HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med (2007) 1.87
Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med (2008) 1.83
Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J (2012) 1.71
Subgingival microbial profiles of smokers with periodontitis. J Dent Res (2010) 1.70
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med (2006) 1.58
Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS (2004) 1.54
Cardiovascular risk in chronic obstructive pulmonary disease. Respirology (2007) 1.36
Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol (2009) 1.27
Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients. J Clin Microbiol (2009) 1.20
Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era. AIDS (2012) 1.18
Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax (2011) 1.16
Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One (2013) 1.15
Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases. Semin Respir Crit Care Med (2009) 1.14
Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environ Microbiol (2012) 1.06
Pneumocystis colonization in HIV-infected patients. J Eukaryot Microbiol (2003) 1.06
Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic Biol Med (2012) 1.00
Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol (2012) 0.95
Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis (2009) 0.94
Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension. AIDS Res Hum Retroviruses (2012) 0.91
Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology (2008) 0.89
Serum (1→3)-β-D-glucan levels in HIV-infected individuals are associated with immunosuppression, inflammation, and cardiopulmonary function. J Acquir Immune Defic Syndr (2012) 0.88
Association of COPD with carotid wall intima-media thickness in vascular surgery patients. Respir Med (2009) 0.88
Pulmonary hypertension in a stable community-based COPD population. Lung (2011) 0.87
Contributors to diffusion impairment in HIV-infected persons. Eur Respir J (2013) 0.85
Probiotic fortified diet reduces bacterial colonization and translocation in a long-term neonatal rabbit model. J Pediatr Surg (2009) 0.76